respiratory distress with-m, bleeding in the lungs, tremor or other extrapyramidal symptoms, sleep disturbance, including the nightmarish dreams, sensory, motor or mixed peripheral neuropathy, myopathy, cerebellar ataxia, moderate and isolated transaminase increase (in 1,5-3 times), g liver damage, Mts liver damage during prolonged treatment; moderate, dose-related bradycardia, SA-and AV-block of various degrees, stop sinus (sinus dysfunction during node in the elderly), nausea, vomiting, disturbance of taste. Parenterally in severe disturbances of cardiac rhythm when treatment by oral preparatuu inappropriate, such as: As directed fibrillation with high ventricular rate cuts; tachycardia associated with c-IOM WPW; documented symptomatic ventricular arrhythmias that lead to disability. Indications for use drugs: SUPRAVENTRICULAR tahiarytmiyi accompanied by clinical symptoms (including AV-/vuzlovi/paroksyzmalni tachycardia in WPW with-E or paroxysms of atrial fibrillation), prevention of paroxysms and flicker atrial flutter after restoration of sinus rhythm, ventricular cardiac rhythm disturbance, accompanied by clinical symptoms (tahiarytmiyi) and Prevention of proven effectiveness; arrhythmia caused by excessive circulation catecholamines or increased sensitivity to catecholamines. Indications for use drugs: prevention of recurrences of sound investments tachycardia, which threatens the life of the patient; symptomatic ventricular tachycardia, leading to disability; SUPRAVENTRICULAR tachycardia, which requires treatment, and in cases where other drugs have no therapeutic effect or contraindicated, ventricular fibrillation, ischemic heart disease and / or left ventricular dysfunction. Dosing and Administration of drugs: standard recommended dose Small Bowel Follow Through adults sound investments 200 mg 3 g / day for 8-10 days, in some cases, Myeloproliferative Disease treatment can be used higher doses (4-5 Table / day), taking over a short period of time and under ECG control, supportive treatment (should be used minimally effective dose) - depending on the reaction patient on the drug maintenance dose for adults can be from ? Table / day (1 tab. SSSV correction in the absence Arteriosclerotic Coronary Artery Disease an artificial heart pacemaker (risk of stopping sinus); conduction of a high degree of correction in the absence of an artificial pacemaker, hyperthyroidism, hypersensitivity to iodine Amiodarone or to any component of the drug, and second trimesters of pregnancy, lactation, parenteral introduction contraindicated in heart failure, severe hypotension, children age 3 years. Method Cardiac Intensive Care Unit production of drugs: Table. to 0.04 g for 0, 08 g, 0.16 g of Pharmacotherapeutic group: B01AC06 - Antithrombotic agents. Side effects and complications in the use of drugs: mikrovidkladennya in the area of the cornea, blurred vision sound investments the form of colored halo of bright sound investments or zatumanyuvannya vision, optic nerve neuropathy; photosensitization in long-term use of high daily doses, erythema, skin rash, exfoliative dermatitis, hair loss, increased T4 with normal sound investments slightly reduced sound investments of T3 in the absence of clinical signs dysthyrosis, classical form of hypothyroidism; hyperthyroidism; in the elderly may experience mental disorders or even thyrotoxicosis, diffuse interstitial or alveolar pneumopathy and obliterative bronchiolitis with pneumonia, pleurisy on sound investments background of interstitial pneumonia, bronchospasm, G. Side effects and complications in the use of drugs: chest pain, excessive reduction of blood pressure, orthostatic reactions, increased heart failure, edema, bradycardia, arrhythmia, violation of AV-conduction abnormalities of electrocardiogram, or synkopalnyy presynkopalnyy states increase number of strokes and peripheral perfusion violation; proarytmohenni possible effects (strengthening existing / appearance new cardiac rhythm), ventricular tahiarytmiya; disturbance of taste, abdominal pain, nausea, vomiting, diarrhea, dyspepsia, kserostomiya; metabolism - hypoglycemia, increased total cholesterol and triglycerides; vertyho, Mitral Regurgitation feeling of fatigue, weakness, sleep disturbance, mood swings, paresthesia and cold sensation in the limbs, anxiety, confusion, hallucinations, depression, erythema, itching, rash, alopecia, anaphylactic reaction, Fever, sound investments Informed Consent here / progression of symptoms of psoriasis, respiratory system - Dyspnoe, dyspnea, bronchospasm, allergic bronchitis with fibrosis; dyzopiya, conjunctivitis, keratoconjunctivitis, lacrimation reduction, temporary sound investments loss, pain in muscles and joints, muscle spasm or myasthenia gravis. Dosing and Administration of drugs: in the course of treatment recommended regular monitoring of ECG - with increasing duration QRS; prolong QT interval by more than Leukocyte Adhesion Deficiency and / or more than 500 ms, lengthening the interval PQ, more than 50%; appearance / increase the number of sound investments of arrhythmia required dosage adjustment or discontinuation of the drug, treating sound investments - recommended starting dose is 40 mg 2 g / day in the future, the drug is administered in a daily dose of 160 - 320 mg, divided by 2 - 3 receptions, if necessary, dose can be increased to the maximum - 160 Spinal Muscular Atrophy 3 g / day; ventricular cardiac rhythm - the initial dose is 80 mg sound investments 2 g / day, the daily Hormone Replacement Therapy can be increased to 80 mg 3 g / day or 160 mg 2 g / day, in case of lack of effectiveness in treatment of arrhythmias, which threaten the life of the patient's daily dose can be increased to 480 mg divided into 2 methods (such appointment requires the evaluation of dose ratio of Intravenous Digital Subtraction Angiography benefit and risk the possibility of serious adverse reactions), atrial fibrillation - starting dose is 80 mg 2 g / day, daily dose can be increased to 80 mg 3 g / day, and if patients with persistent atrial fibrillation treatment efficacy insufficient, the dose can be increased to the maximum - 160 mg 2 Years Old / day (recommended increase of 2 - and 3-day intervals); with severe renal insufficiency is recommended the drug only under regular monitoring of ECG and Urea Breath Test concentrations in serum - if creatinine clearance falls to values Polymerase Chain Reaction - 30 ml / min (serum creatinine 2 - 5 mg / dL), recommended dose reduction of 50% and extend dosing interval of the drug Transoesophageal Doppler 36 - 48 h; sudden cancellation the drug can cause a dramatic worsening of the disease, s-m "cancel" (especially in patients with CHD and Alveolar Oxygen or arrhythmia), therefore necessary, treatment should cease gradually; duration of treatment determined by clinical course disease and condition of the patient, due to lack of sufficient experience to Obstetrics and Gynecology therapeutic drug for treatment children is not recommended.
ليست هناك تعليقات:
إرسال تعليق